Concomitant tacrolimus (TAC) and methotrexate (MTX) pharmacokinetics (PK) in rheumatoid arthritis (RA) patients.

被引:0
|
作者
Holum, MB [1 ]
Wisemandle, W [1 ]
Bekersky, I [1 ]
机构
[1] Fujisawa Healthcare Inc, Res & Dev, Deerfield, IL USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 42卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
11
引用
收藏
页码:1053 / 1053
页数:1
相关论文
共 50 条
  • [1] Pharmacokinetics (PK) of etanercept are unaltered by concurrent administration of methotrexate (MTX) in rheumatoid arthritis (RA) patients.
    Zhou, HH
    Buckwalter, M
    Mayer, P
    Raible, D
    Wajdula, J
    Fatenejad, S
    Sanda, M
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S139 - S139
  • [2] Effects of renal insufficiency on pharmacokinetics of methotrexate (MTX) in rheumatoid arthritis (RA) patients.
    Combe, B
    Kinowski, JM
    Bologna, C
    Sany, J
    Bressolle, F
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 382 - 382
  • [3] EFFECTS OF ETODOLAC ON METHOTREXATE (MTX) PHARMACOKINETICS IN RHEUMATOID-ARTHRITIS (RA) PATIENTS
    ANAYA, JM
    FABRE, D
    BRESSOLLE, F
    ALRIC, R
    DROPSY, R
    SANY, J
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S343 - S343
  • [4] Folic acid alters methotrexate (MTX) disposition in rheumatoid arthritis (RA) patients.
    Combe, B
    Kinowski, JM
    Pouly, B
    Sany, J
    Bressolle, F
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S76 - S76
  • [5] Treatment of interleukin-1 receptor antagonist in combination with methotrexate (MTX) in rheumatoid arthritis (RA) patients.
    Cohen, S
    Hurd, E
    Cush, JJ
    Schiff, MH
    Weinblatt, ME
    Moreland, IW
    Bear, M
    Rich, W
    McCabe, DP
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S273 - S273
  • [6] METHOTREXATE (MTX) METABOLISM IN RHEUMATOID-ARTHRITIS (RA)
    GALIVAN, J
    KAMEN, B
    KREMER, JM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 194 - 194
  • [7] Cellcept® (mycophenolate mofetil MMF) and methotrexate (MTX):: Safety and pharmacokinetic (PK) interaction study in rheumatoid arthritis patients.
    Yocum, D
    Kremer, J
    Blackburn, W
    Caldwell, J
    Furst, D
    Nunez, M
    Zuzga, J
    Zeig, S
    Gutierrez, M
    Merrill, J
    Dumont, E
    Leishman, B
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S83 - S83
  • [8] ASSOCIATION OF METHOTREXATE (MTX) AND STEROIDS IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA) PATIENTS
    BOLOGNA, C
    VIU, P
    JORGENSEN, C
    SANY, J
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1280 - 1280
  • [9] PHARMACOKINETICS OF LOW-DOSE METHOTREXATE (LD-MTX) IN RHEUMATOID-ARTHRITIS (RA)
    FURST, DE
    HAUB, R
    FAULKNER, R
    HOFFMAN, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 193 - 193
  • [10] IMMUNOREGULATORY EFFECTS OF METHOTREXATE (MTX) IN RHEUMATOID-ARTHRITIS (RA)
    OLSEN, N
    MURRAY, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 169 - 169